Frédérique Schaff-Wendling

Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis.

B. Goichot, G. Malouf, A. Imperiale, 2018, Clinical nuclear medicine.

Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak

T. Petit, J. Limacher, M. Velten, 2022, Clinical Breast Cancer.

COVID‐19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS‐CoV‐2 Cluster During the First Wave of the COVID‐19 Pandemic

J. Limacher, P. Barthélémy, O. Clerc, 2021, The oncologist.

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

J. Céraline, T. Ye, C. Keime, 2017, Oncotarget.

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

J. Céraline, T. Ye, C. Keime, 2017, Oncotarget.

[Androgen receptor variants in prostate cancer].

J. Céraline, P. Barthélémy, J. Kurtz, 2017, Medecine sciences : M/S.